Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001393905-21-000015
Filing Date
2021-01-25
Accepted
2021-01-25 13:17:24
Documents
1
Period of Report
2020-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 3063
  Complete submission text file 0001393905-21-000015.txt   4659
Mailing Address 5645 MILTON STREET SUITE 130 DALLAS TX 75225
Business Address
Schmidt Donal Ray Jr. (Reporting) CIK: 0001497897 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-55018 | Film No.: 21549119

Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Issuer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations